Reported 2 days ago
MAIA Biotechnology, a cancer drug developer, has surprised Wall Street by announcing a strategy to allocate up to 90% of its liquid assets into cryptocurrencies, including Bitcoin and Ethereum. Following this news, their stock saw a significant increase. While continuing its focus on cancer therapies, the company aims to diversify its investment portfolio through high-quality digital assets, all while ensuring cybersecurity and compliance with financial regulations.
Source: YAHOO